How Signant's SmartSignals Solutions Are Shaping Clinical Trial Research

Date Published:

Ian Jennings, Signant’s Chief Commercial Officer, gives a company overview and discusses how the SmartSignals solutions can create a seamless site-patient connection. He also talks about the three different clinical trial approaches and considerations that can affect timelines.

Signant’s Dr. Bill Byrom discusses remote trial components for the following:

  • Informed consent
  • Supply chain & logistics
  • Operations
  • Clinical data collections

Bill also talks about the benefits of integrating digital solutions across these clinical trial areas.